晚期非小细胞肺癌的化疗(4)
17.Fossella FV,Devore R,Kerr RN,et al.randomized phase IIItrial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small cell lung cancer previously treated with platium-containing chemotherapy regimens.The TAX 320 Non-small cell lung cancer study group . J Clin 2000;18:2354-2362
18.Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group. J Natl Cancer Inst 1999 Jan 6;91(1):66-72.
19.Frasci G, Lorusso V, Panza N, Comella P, Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial. Lung Cancer 2001 Dec;34 Suppl 4:65-69.
20.Gridelli C, Perrone F,Cigloari S,et al. The MILES(Multicenter Italian Lung Cancer in the Elderly Study) phase III trial :gemcitabie+vinorelbine vs vinorelbine and vs gemcitabie in elderly advanced NSCLC patients.Proc Am Soc Clin Oncol,2001;20:1230a., 百拇医药(冯卫能，吴一龙，谷力加，翁毅敏，程超)
18.Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group. J Natl Cancer Inst 1999 Jan 6;91(1):66-72.
19.Frasci G, Lorusso V, Panza N, Comella P, Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial. Lung Cancer 2001 Dec;34 Suppl 4:65-69.
20.Gridelli C, Perrone F,Cigloari S,et al. The MILES(Multicenter Italian Lung Cancer in the Elderly Study) phase III trial :gemcitabie+vinorelbine vs vinorelbine and vs gemcitabie in elderly advanced NSCLC patients.Proc Am Soc Clin Oncol,2001;20:1230a., 百拇医药(冯卫能，吴一龙，谷力加，翁毅敏，程超)